Clinical Trial

Clinical Performance and Safety of ENDOPACK® DT4-EBMCA in ACL Reconstruction 24 Months Post-surgery

Study acronym: DT4-EBMCA
Completed
View on ClinicalTrials.gov →
Summary
Anterior cruciate ligament (ACL) injuries are among the most common sports-related knee traumas. The DT4-EBMCA device, based on a quadrupled semitendinosus autograft technique, aims to provide effective and minimally invasive ligament reconstruction. This study evaluates its long-term performance and safety in routine clinical practice.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-18.
Trial Details
NCT Number NCT06990100
Lead Sponsor SACIMEX
Conditions ACL Rupture
Enrollment 36 participants
Start Date 2024-10-01
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-05-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-27